Utilizing the RSClin Tool to Inform Breast Cancer Treatment Decisions in the Practice Setting

Making the HEOR Case for Targeted Therapies - From Biomarkers to Benefits

Written by: Hayleigh Culliton, HealthEconomics.com & Matt McLoughlin, Scientist.com The concept of precision (or personalized) medicine is not new. Arguably the first example of personalized medicine was the implementation of anticoagulation clinics in the early 1960s to support the administration of Warfarin1. This shift was due to the drug’s narrow therapeutic window and risk of bleeding or clotting, which required specialized clinics to be de…

Utilizing the RSClin Tool to Inform Breast Cancer Treatment Decisions in the Practice Setting

Panelists discuss how the RSClin tool provides more personalized information by combining recurrence scores with clinicopathological data, offering patients specific predictions about their prognosis and potential chemotherapy benefit rather than general outcomes for patients with similar scores.